CURRICULUM VITAE FOR
JAN AKERVALL, MD., PH.D.
Revised March, 2004
|
| Education |
|
|
| High
School education: |
1976-1979 |
St Lars High
School, Linkoping, Sweden; Natural science program
|
Undergraduate education:
|
1981-1982 |
Chalmers Institution
of Technology, Gothenburg, Sweden: Theoretical Physics |
| |
1980-1981 |
Linkoping University,
Sweden; Mathematics |
| |
1991-1992 |
Internship
(AT), Angelholms sjukhus, Sweden |
Medical school:
|
1983-1989 |
Medical
School, Lund University, Sweden |
| PhD degree |
1993-1998 |
Lund University, dept of ORL/H&N Surgery,
Lund, Sweden;
(Thesis: Prognostic markers in squamous cell carcinoma
of the head and neck, mentors: Prof Johan Wennerberg, dept of ORL,
and Associate Prof Fredrik Mertens, dept of Clinical Genetics).
Courses in Epidemiology (1993), Research Methodology (1994), Molecular
Biology
for oncologists (1994), DNA-based Clinical Diagnistics (1995),
Information sources (1995), Genetics and Cancer (1996), Methodology
of publication
(1996 & 1997), Survival analysis (1996), Medical Ethics (1997),
Problem based education/tutor course (1998). |
| |
1993-1998 |
ENT training, clinical, including courses in Leadership,
Otoneurology, Middle ear surgery, Sinus surgery, Laryngology, Radiobiology,
Radiation Oncology |
| |
1994-1999 |
Pain treatment in cancer patients (Swedish Cancer Society) |
Academic
Appointments:
|
1986-1987 |
Lecturer in Pathology, Lund University, Sweden |
| |
1994-1996
|
Lecturer in Otolaryngogly/Head & Neck
Surgery, Lund University, Sweden |
| |
1996 - 1997
|
Member of the board of The Jubilee Institution, University Hospital,
Lund, Sweden |
| |
1996-1997
|
Member of the Educational Board at Medical Faculty, Lund
University. Introduced mandatory basic science education for doctoral
students. |
| |
1998-1999
|
Head of education program for ENT specialists in southern
Sweden
|
| |
2000-2001 |
Head and neck tumour and reconstructive surgery fellow,
Dept of Otolaryngology, Head and Neck Surgery, University of Michigan,
Ann Arbor, Michigan, USA.
Postdoc in tumour Biology, Dept of Otolaryngology, Head and Neck Surgery, University
Hospital, Ann Arbor, Michigan, USA
|
| |
2003 |
Associate Professor,
Dept of Otolaryngogly/Head & Neck
Surgery, Lund University, Sweden
|
| |
2003 |
Head of education program for ENT specialists in southern
Sweden
|
| Certification
and Licensure: |
|
|
| |
1990 |
MD, Lund University, Sweden |
| |
1998
|
Board Certification, ENT, Head and Neck Surgery, Sweden |
| |
2000
|
Temporary Academic License, Michigan |
| |
2002
|
Permanent MD license, Michigan (Permanent I.D. no. 4301075498 |
| |
|
|
| Honors
and Awards |
|
|
| |
1996 |
Best poster award, Swedish Society for Otorhinolaryngology |
| |
1998
|
Tegger Foundation, Malmoe, Sweden |
| |
1998
|
Teknibro Foundation, Lund University, Sweden |
| |
2004
|
Buyers award nomination, 6th International Conference on Head and
Neck Cancer, Washington, August 2004 |
| |
2004
|
Michigan Technological Tri-corridor Fund (2.6 Mill dollars
for SensiGen corp.) |
| Commercial
Scientific Achievements |
|
|
| |
2001 |
Incorporator, SensiGen Corporation.
|
| |
2002 |
US Patent 6,341,608 B1 (January 29, 2002). Novel surgical method
of resecting tumors. |
| Sscholarships |
|
|
| |
1994 |
GAE Nilssons Foundation
Maggie Stephens Foundation |
| |
1995
|
The Swedish Society of Medicine
The Lund Society of Medicine
Swedish Cancer Foundation |
| |
1996
|
Swedish Cancer Foundation
Maggie Stephen's Foundation
The Royal Fysiographic Society |
| |
1997
|
GAE Nilssons Foundation
Maggie Stephens Foundation |
| |
1998
|
Maggie Stephen's Foundation |
| |
1999
|
Maggie Stephen's Foundation |
| |
2000
|
Swedish Cancer Society, postdoc scholarship Swedish Society for
Medical Research, postdoc scholarship |
| |
2002
|
GAE Nilssons Cancer Society |
| |
2003
|
GAE Nilssons Cancer Society, Maggie Stephen's Foundation |
| |
| |
| Memberships
and Offices in Profesional Societies |
The
Swedish Society of Medicine
The Lund Society of Medicine
Swedish Medical Association
The southern swedish oncologic society
Swedish Society for Otorhinolaryngology, Head and Neck Surgery
Scandinavian Society for Head and Neck Oncology
American Association for Cancer Research (AACR)
American Academy of Otolaryngology – Head and Neck Surgery (AAO-HNS).
Michigan Oto-Laryngological Society
|
| Extramural
Invited Presentations |
”Cyclin
D1 in squamous cell carcinoma of the head and neck”. Invited lecture
at Danish Society for Head and Neck Oncology, Copenhagen, Denmark,
February 1, 1997, and at 4th International Conference on Head
and Neck Cancer Biology,
Mc Lean, USA, August 1998
“Predictive markers in squamous cell carcinoma of the head and
neck”. Invited lecture and panel discussion for EUFOS 2000 (European
Otolaryngology Academy meeting), Berlin, Germany, May 2001
“Genetic markers to individualize treatment of squamous cell carcinoma
of the head and neck.” Invited lecture 8th World Congress on Advances
in Oncology, Crete, Greece, October 2003.
“Limiting cancer spread – prevention of implantation metastases”.
Invited lecture 2nd European Conference on Head and Neck Surgery,
Lille, France, October 2003.
“Gene profiling in squamous cell carcinoma of the head and neck”.
Invited lecture and panellist at EUFOS 2004, Rhodes, Greece, September,
2004.
“Bone anchored Mucosal flap for reconstruction of anterior floor of mouth and
gingival.” Michigan Otolaryngological Society, Bay Harbour, Michigan, USA,
July 2005.
|
| Invited
Charimarn at Scientific Meetings |
4th International Conference on Head and Neck Cancer Biology,
Mc Lean, USA, August 1998
3rd European Workshop on Head and Neck Cancer Biology, Oslo, Norway,
April 1998.
The International Symposium on Metastasis in Head Neck Cancer,
Marburg, Germany, January 25-27, 2001
The Fourth European Workshop on Head and Neck Biology, Amsterdam,
Netherlands, October 3-6, 2001
VII Symposium on research in Head and Neck Cancer, Dusseldorf,
Germany, September 5-8, 2003
8th World Congress on Advances in Oncology, Crete, Greece, October
16-18, 2003
|
| Research
Collaborators |
Prof. F Mertens, MD, PhD, Dept of Clinical Genetics, University
Hospital, Lund, Sweden, since 1993. Cytogenetic studies
Assoc prof. U Zatterstrom, MD, PhD, Dept of Otolaryngology, Head and Neck Surgery,
Rikshospitalet, Oslo, Norway, since 1993. Malignancy grading studies
Assoc prof. A Borg, PhD, Dept of Oncology, University Hospital, Lund, Sweden,
since 1995 Differential PCR, FISH
Prof. J Isola, MD, PhD, Dept of Medical Technology, Tampere University, Finland,
since 1996. FISH
Prof. F Balm, MD, PhD and R Michalides, PhD, Netherlands Cancer Institute, Amsterdam,
The Netherlands, since 1996. Cyclin D1immunohistochemistry
Prof. T Carey, PhD, University of Michigan, Ann Arbor, USA, since 1998. Cell
culture, western blotting, chemosensitivity studies. Head of current lab (postdoc)
Prof. A El-Naggar, MD, PhD, Dept of Pathology, MD Anderson Cancer Institute,
Houston, Texas, USA, since 1998. Multi-center cyclin D1 study
Assoc prof. C Bradford, MD, Dept of Otolaryngology, Head and Neck Surgery, University
of Michigan, Ann Arbor, USA, since 2000. Chemosensitivity studies, microvascular
reconstructive surgery
Prof. B Teh, MD, PhD, Van Andel Research Institute, Grand Rapids, Michigan, USA,
since 2000. Spectro karyotyping, cDNA and CGH micro-arrays
Prof. R Greinman, MD, PhD, Dept of Otolaryngology, Head and Neck Surgery, Abo
University, Finland, since 2000. Cell culture and cytogenetic.
Priv doc, Dr Dr H Bier, MD, PhD, Dept of Otolaryngology, Head and Neck Surgery,
Dusseldorf University, Germany, since 2000. Cell culture and cytogenetic
.
Priv doc, Dr Dr U Bockmuhl, MD, PhD, Dept of Otolaryngology, Head and Neck Surgery,
Humbolt University, Berlin, Germany, since 2001. CGH vs real-time PCR study.
Prof. Mans Magnusson, Dept of ENT, Lund, Sweden. International Head and Neck
Cancer Biology studies.
Dr. Peter Chen, M.D., Beaumont Hospital, Royal Oak, Michigan. Genetic markers
for head and neck cancer
Dr. Neal Goldstein, M.D., Beaumont Hospital, Royal Oak, Michigan. Genetic markers
for head and neck cancer
|
| Research
Supervision |
Supervised 2 nurses and 7 medical students in clinical studies
(Lund, Sweden, and Ann Arbor, Michigan, USA), 1997-2003
Co-supervisor (bitr handledare) 2 doctoral students (ENT and Oncology) 2003
Supervising 2 residents at William Beaumont Hospital in Head and
Neck Cancer studies.
|
Clinical Supervision |
Surgical supervision of residents in University of Michigan, Department
of Otolaryngology, 2000-2002, and at Lund University, Department of
Otolaryngology 1998-1999, and 2002- |
| |
|
| Newspaper
Articles and other media cover of Jan Akervall |
Medical thesis about prognostic markers in head and neck cancer
awarded by Tegger’s foundation. Skanska Dagbladet (Swedish newspaper)
1998
New surgical procedure for reconstructions of anterior floor
of mouth defects. Dagens Medicin (Daily Medicine) 2003.
Re-organisation based on personal responsibility cuts waiting
lists. Lakartidningen (National journal for Swedish physicians)
2004
New model for health care organization cuts waiting lists. Dagens
Medicin (Daily Medicine) 2004
Personal responsibility cuts waiting lists – new organizational
model. Kvalitetsmagasinet (Swedish national magazine for public
and private organizations) 2004.
3 years waiting list for thyroidectomies became 3 weeks by new
organizational method. Dagens Eko (National public Radio, Sweden)
2004.
Dramatically shortened waitng lists for elective surgery by new
method. TV4 news (National TV news, Sweden) 2004.
8 He cut the waiting lists by a smarter organization. Fokus (Swedish
Newsweek) 2005.
|
| Bibliography |
| Completed
publications in Scientific Journals |
| Peer
reviewed Publications |
J
Rollof, J Akervall and J Rydberg. Are tumour necrosis factor
(TNF) or Cortisol of value for the diagnosis of acute septicemia?
Scand
J Infect Dis 22: 507-508, 1990.
J Akervall, Y Jin, J Wennerberg, U K Zatterstrom,
E Kjellen, R Willen, F Mertens, N Mandahl, S Heim and F Mitelman.
Chromosomalabnormalities
involving 11q13 are associated with poor prognosis in squamous
cell carcinoma of the head and neck. Cancer 76:853-859, 1995
Y Jin, F Mertens, C Jin, J Akervall, J Wennerberg,
L Gorunova, N Mandahl, S Heim and F Mitelman. Nonrandome chromosome
abnormalities
in short-term cultured primary squamous cell carcinoma of the
head and neck. Cancer Res 55:3204-3210, 1995.
J Akervall, R Michalides, H Mineta, A Balm, A Borg,
M Dictor, Y Jin, B Loftus, F Mertens, P Wahlberg, and J Wennerberg.
Amplification
of cyclin D1 in squamous cell carcinoma of the head and neck
and the prognostic value of chromosomal abnormalities and cyclin
D1
overexpression. Cancer 79:380-389, 1997.
C Jin, Y Jin, J Wennerberg, J Akervall, B Grenthe,
N Mandahl, S Heim, F Mitelman, and F Mertens. Clonal chromsome
aberrations
accumulate with age in upper aerodigestive tract. Mutation Res
374:63-72, 1997.
C Jin, Y Jin, J Wennerberg, J Akervall, M Dictor,
N Mandahl, S Heim, F Mitelman, and F Mertens. Cytogenetic analysis
of inverted
nasal papillomas and demonstration of genetic convergence during
in vitro passaging. Int J Cancer 70:668-673, 1997.
J Akervall, Y Jin, B Baldetorp and J Wennerberg.
Complex karyotypes in flowcytometrically DNA-diploid squamous
cell carcinomas of the
head and neck. Br J Cancer 77:1082-1088, 1998.
C Jin, Y Jin, M Hoglund, J Wennerberg, J Akervall,
R Willen, M Dictor, N Mandahl, F Mitelman and F Mertens. Cytogenetic
and molecular
genetic demonstration of polyclonality in an acinic cell carcinoma.
Br J Cancer 78:292-295, 1998.
H Mineta, A Borg, M Dictor, P Wahlberg, J Akervall,
and J Wennerberg. p53 mutation, But not p53 expression, correlates
with survival in
head and neck carcinoma. Br J Cancer 77:1082-1088, 1998.
Y Jin, M Hoglund, C Jin, C Martins, J Wennerberg,
J Akervall, N Mandahl, F Mitelman and F Mertens. FISH characterization
of head
and neck carcinomas reveals that amplification of band 11q13
is associated with distal deletion of 11q. Genes, Chromosomes & Cancer
22:213-320, 1998.
G Thorneman, and J Akervall. Pain treatment after
tonsillectomy: Advantages for regularly given analgesics compared
with given on
demand. Acta Otolaryngologica, Stockholm 120; 986-989; 2000
J Akervall, R Michalides, M Dictor, E Brun, F
Balm, and J
Wennerberg. Cyclin D1 overexpression versus response to induction chemotherapy
in squamous cell carcinoma of the head and neck. Acta Oncologica 40;505-12;
2001.
J Akervall, A Borg, M Dictor, Y Jin, F Mertens,
and J Wennerberg. Chromosomal translocations involving 11q13 contribute
to cyclin
D1 overexpression in squamous cell carcinoma of the head and
neck. Int J Oncol 2002;20; 45-52.
C Jin, Y Jin, J Wennerberg, J Akervall, M Dictor,
and F Mertens. Karyotypic heterogeneity and clonal evolution in
squamous cell carcinomas
of the head and neck. Cancer Genet Cytogenet 132; 85-96; 2002.
J Akervall, U Bockmuhl, P Pedersen, T Carey, and
D Kurnit.The gene ratios c-myc/p16 and cyclin D1/p16 correlates
with poor prognosis
in squamous cell carcinoma of the head and neck. Clin Cancer
Res. 2003;9;1750-1755.
J Akervall, D Kurnit, M Adams, B Zhu, S Fisher,
C Bradford, and T Carey. Overexpression of Cyclin D1 Correlates
with Sensitivity
to Cisplatin in Squamous Cell Carcinoma Cell Lines of the Head
and Neck. Acta Otolaryngol 124:851-857, 2004
E Nimeus, K Rennstam, J Wennerberg, J Akervall,
M Ferno. Amplification of Cyclin D1, ploidy status and s-phase
fraction correlates with
tumor localisation in squamous cell carcinoma of the head and
neck. Oral Oncol. 2004 Jul;40(6):624-9.
J Akervall, X Guo, M Qian, J Schoumans, A Cole,
B Leeser, J Resau, C Bradford, T Carey, J Wennerberg, H Anderson,
J Tennvall,
B T. Teh Genetic and expression profiles of squamous cell carcinoma
of the head and neck correlate with cisplatin sensitivity and
resistance in cell lines and patients. Clin Cancer Res. 2004 Dec
15;10(24):8204-13.
M Dictor, M Ehinger, F Mertens, J Akervall and
J Wennerberg. Abnormal cell regulation in malignancy. Am J Pathol
112 (suppl.
1):40-52, 1999.
J Akervall. Genetic profiling in squamous cell carcinoma
of the head and neck. Cancer Met Rev 24:87-94, 2005
J Akervall. Genomic screening of head and neck
cancer. European Archives of Oto-Rino-Laryngology (in press).
E. Henriksson, J. Akervall et al. p53 mutation
and cyclin D1 amplification correlate with cisplatin sensitivity
in xenografted
human squamous cell carcinomas from head and neck. Acta Oncologica
(in press).
|
| Book chapters |
J Akervall, F Mertens and J Wennerberg. Chromosomal abnormalities
in squamous cell carcinoma of the head and neck. In Kitamura K.,
Steel KP (eds.): ”Genetics in ORL. Adv Otorhinolaryngology”, Basel,
Karger,
2000;56:261-7
|
| Medical thesis |
J Akervall. Prognostic factors in squamous cell carcinoma of
the head and neck. With emphasis on 11q13 rearrangements and
cyclin D1 overexpression. (1998)
|
| |
|
| Extensive proceedings |
J Akervall, R Michalides, H Mineta, A Balm, A Borg, M Dictor,
Y Jin, B Loftus, F Mertens, P Wahlberg, and J Wennerberg. Amplification
and overexpression of cyclin D1, and chromosomal abnormalities
in squamous cell carcinoma of the head and neck. In Head and Neck
Cancer
Advances in Basic Research, pp 213-218, Elsevier, Amsterdam-Lausanne-New
York-Oxford-Shannon-Tokyo, 1996.
J Wennerberg, B Baldetorp and J Akervall. The efficacy of
DNA flow cytometry in squamous cell carcinoma of the head and
neck. In Head and Neck Cancer Advances in Basic Research, pp
599-605, Elsevier,Amsterdam-Lausanne-New York-Oxford-Shannon-Tokyo,
1996.
J Akervall, David Kurnit, Meredith Adams, Bob Zhu, Susan Fischer,
Carol Bradford, and Thomas Carey. Deregulation of cyclin D1 and
p16 and their relation to Cisplatin sensitivity in squamous cell
carcinoma cell lines of the head and neck. In Metastases in Head
and Neck Cancer, pp 223-226, Tectum Verlag, Marburg, Germany
2001.
|
| |
|
| Articles submitted for publication |
J Akervall, J Prager, D Kurnit, T Ogawa, T Carey, and C Bradford.
Characterization of homzygous deletions affecting tumour suppressor
genes p16INK4A and p14ARF in 25 squamous cell carcinoma of the
head and neck cell lines.
J Akervall. Bone anchored mucosal flap for reconstruction of
anterior floor of mouth after tumor resection including partial
mandibulectomy – pilot study of 8 patients.
|
| |
|
| Abstract presentations since 2000 (during 1994-2000: another 26
abstract presentations in different international meetings) |
Predictive
markers in squamous cell carcinoma of the head and neck. Presented
at EUFOS 2000, Berlin 13-18 Maj, 2000-05-22 J Akervall
(invited speaker)
Etablering och karaktarisering av sex humana skivepitelcancercellinjer
fran huvud- och halsregionen. Presented at the Swedish National
Medical Conference, Stockholm 2000-11-29—12-01 E.Lundahl,
B. Baldetorp, F. Mertens, P. Wahlberg, J. Wennerberg and
J. Akervall
Amplifiering av cyclin D1 genen CCND1 i skivepitelcancer
i huvud- och halsregionen. Presented at the Swedish National
Medical Conference,
Stockholm 2000-11-29—12-01 E. Nimmeus, K. Annertz, M. Ferno,
J. Akervall, and J. Wennerberg.
Overexpression of Cyclin D1 Correlates with Sensitivity
to Cisplatin in Squamous Cell Carcinoma Cell Lines of the
Head and Neck. J Akervall, D Kurnit, M Adams, B Zhu, S Fisher,
C
Bradford, and T Carey. Presented at The International Symposium
on Metastasis in Head Neck Cancer, Marburg, Germany, January
25-27, 2001
Overexpression of Cyclin D1 Correlates with
Sensitivity to Cisplatin in Squamous Cell Carcinoma Cell
Lines of the Head and
Neck. J Akervall, D Kurnit, M Adams, B Zhu, S Fisher, C Bradford,
and T Carey. Presented at The American Association for Cancer
Research 92nd Annual Meeting, New Orleans, Lousiana, USA,
March 24-28, 2001
Overexpression of Cyclin D1 Correlates with
Sensitivity to Cisplatin in Squamous Cell Carcinoma Cell
Lines of the Head and
Neck. J Akervall, D Kurnit, M Adams, B Zhu, S Fisher, C Bradford,
and T Carey. Presented at University of Michigan Translational
Cancer Conference, USA, April, 2001
Overexpression of Cyclin D1 Correlates with
Sensitivity to Cisplatin in Squamous Cell Carcinoma Cell
Lines of the Head and
Neck. The Fourth European Workshop on Head and Neck Biology,
Amsterdam, Netherlands, October 3-6, 2001
J Wennerberg, C Jin, Y Jin, J Akervall, M Dictor, and F
Mertens. Klonal evolution och cytogenetisk heterogenitet
i skivepitelcancer
i huvud- och halsregionen. Presented at the Swedish National
Medical Conference, Stockholm , 2001-11-28—30
Amplification of p53 I squamous cell carcinoma cell lines.
Presented at The American Association for Cancer Research
93nd Annual Meeting, San Francisco, California, USA, April
6-10, 2002:
Genetic and expression profiles of squamous cancer cell lines
of the head and neck correlate with cisplatin sensitivity
and resistance. Jan Akervall, Xiang Guo, Miles Qian, Jacqueline
Schoumans,
Jason Yuhas, Andrew Cole, Brandon Leeser, James Resau, Carol
Bradford, Thomas Carey, Harald Anderson, Jan Tennvall,
Bin T. Teh Presented
at The American Association for Cancer Research 93nd Annual
Meeting, Washington, USA, July 10-14, 2003
Presented at Scandinavian Society for Head and
Neck Oncology, Trondheim, Norway, May 2-4, 2003, Jan Akervall,
Xiang Guo, Miles
Qian, Jacqueline Schoumans, Jason Yuhas, Andrew Cole, Brandon
Leeser, James Resau, Carol Bradford, Thomas Carey, Harald
Anderson, Jan
Tennvall, Bin T. Teh Presented at The American Association
for Cancer Research 93nd Annual Meeting, Washington, USA,
July 10-14, 2003
Presented at ECCO12, Copenhagen, Denmark, September 21-25,
2003, Jan Akervall, Xiang Guo, Miles Qian, Jacqueline Schoumans,
Jason Yuhas, Andrew Cole, Brandon Leeser, James Resau, Carol
Bradford, Thomas Carey, Harald Anderson, Jan Tennvall,
Bin T. Teh Presented
at The American Association for Cancer Research 93nd Annual
Meeting, Washington, USA, July 10-14, 2003.
Presented at VII Symposium on research in Head
and Neck Cancer, Dusseldorf, Germany, September 4-6, 2003.
Jan Akervall, Xiang Guo,
Miles Qian, Jacqueline Schoumans, Jason Yuhas, Andrew Cole,
Brandon Leeser, James Resau, Carol Bradford, Thomas Carey,
Harald Anderson,
Jan Tennvall, Bin T. Teh Presented at The American Association
for Cancer Research 93nd Annual Meeting, Washington, USA,
July 10-14,
2003
Akervall, U Bockmuhl, P Pedersen, T Carey, and
D Kurnit.The gene ratios c-myc/p16 and cyclin D1/p16 correlates
with poor prognosis
in squamous cell carcinoma of the head and neck. Presented
at Scandinavian Society for Head and Neck Oncology, Trondheim,
Norway May 2-4, 2003.
Jan Akervall, Xiang Guo, Miles Qian, Jacqueline Schoumans,
Andrew Cole, Brandon Leeser, James Resau, Carol Bradford,
Thomas Carey, Harald Anderson, Jan Tennvall, Bin T. Teh Genetic
and expression
profiles correlate with cisplatin sensitivity and resistance
in cell lines and patients with squamous cell carcinoma of
the head
and neck. Presented at 6th Inrenational Conference on Head
and Neck Cancer, Washington, August 2004:
Jan Akervall, Xiang Guo, Miles Qian, Jacqueline Schoumans,
Andrew Cole, Brandon Leeser, James Resau, Carol Bradford,
Thomas Carey, Harald Anderson, Jan Tennvall, Bin T. Teh Genetic
and expression
profiles correlate with cisplatin sensitivity and resistance
in cell lines and patients with squamous cell carcinoma of
the head
and neck.Presented at Scandinavian Society for Head and Neck
Oncology, Oulo, Finland, April 2004:
J Akervall. Bone anchored mucosal flap for reconstruction
of anterior floor of mouth after tumor resection including
partial mandibulectomy – pilot study of 6 patients. Presented
at Scandinavian
Society for Head and Neck Oncology, Oulo, Finland, April 2004.
Jan Akervall, Eugene Rontal, Michael Rontal,
Jens Alm, Paulina Gyllerup, Ylva Gardinger, Johan Wennerberg,
Sarah Scollon, Pete
Haak, Brian Haab, Ed Dere, Kyle Furge, and Bin Teh. Expression
profiles in pre-treatment biopsies from SCC of the head and
neck correlate
with outcome of radiotherapy. AHNS, Boca Raton, Florida, USA
May 15-16, 2005
J Akervall. Bone anchored mucosal flap for reconstruction
of anterior floor of mouth after tumor resection including partial
mandibulectomy – pilot study of 8 patients. Michigan Otolaryngological
Society, Harbor Springs, Michigan, July 2005.
|
| |
|
|
